Lehmann and Lee (2013) recommended monitoring calcium levels more frequently and observing for clinical symptoms in cases of mild asymptomatic hypercalcemia and absence of PTH level elevation while continuing lithium therapy. This evidence concerns the gene PTH and Hypercalcemia.